A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo
Vanderweil, Stefan G. Amano, Shinya U. Ko, Wei-Che Richmond, Jillian M Kelley, Michelle Senna, Maryanne Makredes Pearson, Andrea Chowdary, Sandhya Hartigan, Celia Barton, Bruce A
Vanderweil, Stefan G.
Amano, Shinya U.
Ko, Wei-Che
Richmond, Jillian M
Kelley, Michelle
Senna, Maryanne Makredes
Pearson, Andrea
Chowdary, Sandhya
Hartigan, Celia
Barton, Bruce A
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Letter to the Editor
Publication Date
2017-01-01
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
We conducted a small, randomized, double-blind, placebo-controlled, phase II clinical trial to test simvastatin as a treatment for vitiligo.
Source
J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.jaad.2016.06.015
Permanent Link to this Item
PubMed ID
27986135